Parsatuzumab (Anti-EGFL7)
Product Specifications
CAS Number
1312797-14-0
Synonyms
Anti-EGFL7; RG 7414
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940806-500 1x 500 µL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880693-100 1x 100 µL
CD56 / NCAM (123C3.D5 + 123A8), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881555-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (EGP40/1555R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400716-500 1x 500 µL
Thymidylate Synthase (TS106 + TMS715), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details